Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.
More Latest News
March 4, 2019
The Department of Health has been made aware of an email sent to physicians from SurveyClub. Please click here for more information. Continue reading
February 20, 2019
Medical Marijuana Use Registry fields for qualifying condition (k) do not comply with statutory and rule requirements. Submit form to board within 14-days of certification date. Continue reading